Form 4: Marchex Chairman Horowitz Granted 50,000 Stock Options

Marchex Inc. Chairman Russell C. Horowitz received a grant of 50,000 employee stock options with an exercise price of $1.64, vesting over two years.

Summary

• Russell C. Horowitz, who serves as Chairman, Director, and a 10% Owner of Marchex Inc. (MCHX), was granted 50,000 employee stock options.
• The options have an exercise price of $1.64 per share.
• The grant date for these options was December 16, 2025.
• The options are set to expire on December 16, 2035.
• Vesting will occur in two equal tranches: 50% on December 16, 2026, and the remaining 50% on December 16, 2027, contingent upon continued service on the Board.
• All options will vest immediately upon a Change of Control, as defined in the reporting person's option agreement.

Sentiment

Score: 6

Explanation: Slightly positive, as it indicates continued management commitment and aligns interests with shareholders, though it also introduces potential future dilution.

Positives

• Aligns management's interests (Chairman Russell C. Horowitz) with shareholder value creation through equity incentives.
• The vesting schedule encourages long-term commitment and continued service to the company.
• The exercise price of $1.64 suggests a belief in future stock price appreciation above this level.

Negatives

• Potential for future dilution if the options are exercised, increasing the number of outstanding shares.
• The value of the options is entirely dependent on the future stock price exceeding the exercise price, introducing risk for the recipient.

Risks

• The value of the stock options is subject to market fluctuations and the company's performance, meaning the options may not become in-the-money if the stock price does not rise above $1.64.
• Future stock price volatility could impact the perceived value of this compensation.

Future Outlook

The option grant indicates a continued commitment from Chairman Russell C. Horowitz to Marchex's future performance and growth, with incentives tied to long-term shareholder value creation.

Industry Context

Granting stock options to key executives and directors is a standard practice in the technology and public company sectors to incentivize performance, retain talent, and align leadership interests with those of shareholders.

Comparison to Industry Standards

• The grant of 50,000 stock options to a Chairman, Director, and 10% owner is a common form of executive compensation, comparable to practices at similar-sized public technology companies.
• The 2-year vesting schedule with a change of control clause is also a standard feature in executive equity compensation plans across various industries, including tech companies like Zillow or Redfin, which often use similar structures for their leadership.

Corporate Governance

Stakeholder Impact

• Shareholders: Potential for minor future dilution if options are exercised; improved alignment of management incentives with shareholder interests.
• Management (Russell C. Horowitz): Receives a significant equity incentive tied to the company's future stock performance.

Next Steps

• Continued service of Russell C. Horowitz on the Board to meet vesting conditions.
• Potential exercise of options by Russell C. Horowitz after vesting, assuming the stock price is above the exercise price.

Key Dates

Keywords

Marchex, MCHX, Russell C. Horowitz, stock options, insider transaction, executive compensation, Form 4, equity grant, corporate governance